About Innovassynth Technologies (India ) Limited
Data last updated: 20 December 2025
Innovassynth Technologies (India ) Limited is a public limited company based in Khopoli, Maharashtra, India, a subsidiary of Globus Stores Private Limited. It specialises in specialty chemicals, a part of the broader chemicals and materials sector. Incorporated on 04 December 2001, the company has been in operation for over 25 years.
Registered with ROC Mumbai under CIN U24110MH2001PLC134105.
Capital: an authorised share capital of ₹76 Cr and a paid-up capital of ₹75.02 Cr. It is led by directors including Viren Rajan Raheja and Prosenjit Gupta.
Last AGM: 29 September 2025. Financial statements filed for year ended 31 March 2025. Office: Innovassynth Technologies (India) Limited Old Mumbai – Pune Road, Khopoli, Maharashtra, India – 410203.
As per the financials filed for FY 2025, the company reported a revenue of ₹117.57 Cr, a decline of 27% compared to the previous year.
The company has a workforce of approximately 293 employees as per the latest available data. It operates as a subsidiary of Globus Stores Private Limited.
The company is associated with 1 brand - Innovassynth Technologies. As per MCA filings, the company has open charges of ₹66.24 Cr and satisfied charges of ₹107.95 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website innovassynth.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media
-
Registered AddressInnovassynth Technologies (India) Limited Old Mumbai – Pune Road, Khopoli, Maharashtra, India – 410203
-
IndustryChemicals and Materials, Specialty Chemicals
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Innovassynth Technologies (India ) Limited
Innovassynth Technologies (India ) Limited operates one associated brand: Innovassynth Technologies. These brands represent Innovassynth Technologies (India ) Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Contract research, custom synthesis, and manufacturing services are provided. | innovassynth.com |
Competitors & Alternatives of Innovassynth Technologies (India ) Limited
Brands and companies operating in the same space as Innovassynth Technologies (India ) Limited include Concord Biotech, BDR Pharmaceuticals Internationals, Almac Group and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
|
|
APIs and enzymes are manufactured through fermentation by the CDMO. | Ahmedabad, India, India | 2000 |
|
|
APIs and finished products are developed and manufactured. | Mumbai, India, India | 2003 |
|
|
Integrated CDMO services for biopharma R&D and manufacturing are offered. | Craigavon, United Kingdom, United Kingdom | 2001 |
|
|
APIs manufacturing and formulation services are provided in therapeutic segments. | Mumbai, India, India | 1947 |
|
|
Pharmaceutical dosage forms are manufactured by this CDMO. | Hunt Valley, United States, United States | 1994 |
|
|
Generic biocatalytic solutions are provided for pharmaceutical applications. | Hyderabad, India, India | 1986 |
|
|
Contract manufacturing services for small molecules and peptides are provided. | Ecully, France, France | 2003 |
|
|
APIs and peptides are developed and manufactured by Asymchem. | Morrisville, United States, United States | 1995 |
|
|
Contract research and development services for small molecules are offered. | Greenwich, United States, United States | 2004 |
|
|
MIT-Novartis spinoff offering continuous manufacturing solutions to remove the proverbial wall between API and FDF manufacturing in small molecule development | Woburn, United States, United States | 2012 |
Business Activity of Innovassynth Technologies (India ) Limited
Innovassynth Technologies (India ) Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
Auditor Details of Innovassynth Technologies (India ) Limited
Innovassynth Technologies (India ) Limited is audited by DELOITTE HASKINS & SELLS LLP for the financial year 2024. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| DELOITTE HASKINS & SELLS LLP | blur-value | blur-value | blur-value |
Board of Directors of Innovassynth Technologies (India ) Limited
Innovassynth Technologies (India ) Limited is currently managed by 6 directors, with 23 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Viren Rajan Raheja | Director | 25 Jun 2008 | 18 Years 0 Months | Current |
|
Prosenjit Gupta
Also directs:
Innovassynth Technologies (India) Limited
|
Director | 25 Aug 2023 | 2 Years 10 Months | Current |
|
Ameeta Aziz Parpia
Also directs:
Innovassynth Technologies (India) Limited, Eih Associated Hotels Limited, The Supreme Industries Limited and 1 more
|
Additional Director | 17 Mar 2025 | 1 Years 3 Months | Current |
| Akshay Rajan Raheja | Director | 29 Sep 2022 | 3 Years 9 Months | Current |
|
Hardik Mahesh Joshipura
Also directs:
Innovassynth Technologies (India) Limited
|
Managing Director | 15 Nov 2021 | 4 Years 7 Months | Current |
Financials of Innovassynth Technologies (India ) Limited FY 2025 filings available
Innovassynth Technologies (India ) Limited reported revenue of ₹117.57 Cr (down 27% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Shareholding Pattern of Innovassynth Technologies (India ) Limited
As of FY 2024, Innovassynth Technologies (India ) Limited's shareholding pattern shows 50.00% by promoters, 50.00% by public shareholders.
| Year | 2025 |
|---|---|
| Promoters | 33.19% |
| DII | 23.22% |
| FII | 18.28% |
| Public | 22.89% |
| Others | 2.42% |
Charges & Borrowings of Innovassynth Technologies (India ) Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Oct 2012 | Axis Bank Limited | ₹66.24 Cr | Open |
| 21 Feb 2022 | Axis Bank Limited | ₹21 Cr | Satisfied |
| 14 Dec 2018 | Axis Bank Limited | ₹1.5 Cr | Satisfied |
| 27 Apr 2018 | Axis Bank Limited | ₹5 Cr | Satisfied |
| 29 Jul 2017 | Axis Bank Limited | ₹12.65 Cr | Satisfied |
Total charge records: 16 View all charges
Employees and EPFO Compliance at Innovassynth Technologies (India ) Limited
Innovassynth Technologies (India ) Limited has a workforce of 293 employees as of Apr 06, 2025.
Employee Count & EPFO Data of Innovassynth Technologies (India ) Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Innovassynth Technologies (India ) Limited
GSTIN & GST Filing Data of Innovassynth Technologies (India ) Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Innovassynth Technologies (India ) Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Innovassynth Technologies (India ) Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Innovassynth Technologies (India ) Limited
MSME Payment Delays by Innovassynth Technologies (India ) Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Innovassynth Technologies (India ) Limited
Subsidiaries & Group Companies of Innovassynth Technologies (India ) Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Innovassynth Technologies (India ) Limited with ownership details.
MCA Filings & Documents of Innovassynth Technologies (India ) Limited
MCA Filings & Documents of Innovassynth Technologies (India ) Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Innovassynth Technologies (India ) Limited
Recent News on Innovassynth Technologies (India ) Limited
Frequently Asked Questions about Innovassynth Technologies (India ) Limited
Innovassynth Technologies (India ) Limited is an active public limited company in the chemicals and materials sector based in Khopoli, Maharashtra, India. It was incorporated on 04 December 2001 (25+ years old) and is registered under CIN U24110MH2001PLC134105. The company has 293 employees.
Innovassynth Technologies (India ) Limited reported revenue of ₹117.57 Cr for FY 2025 (down 27.00% YoY).
The current directors of Innovassynth Technologies (India ) Limited are:
- Viren Rajan Raheja
- Prosenjit Gupta
- Ameeta Aziz Parpia
- Akshay Rajan Raheja
- Hardik Mahesh Joshipura
- Jayesh Jagdish Patel
The primary industry of Innovassynth Technologies (India ) Limited is chemicals and materials. The company specifically operates in specialty chemicals. The company is currently active in this sector.
Innovassynth Technologies (India ) Limited can be reached at the registered office: Innovassynth Technologies India Limited Old Mumbai – Pune Road, Khopoli, Maharashtra, India – 410203, or through the website innovassynth.com.
The authorised capital is ₹76 Cr, and the paid-up capital is ₹75.02 Cr.